Press Release Archive

12.06.2010

Angie Harmon and Children's Advil® Invite Families to Sing Away the Cold and Flu Season Blues

12.05.2010

National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's'

12.05.2010

Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia

12.05.2010

Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer

12.03.2010

Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia

12.01.2010

AVERROES Study of Investigational Agent Apixaban Closes Early Due to Clear Evidence of Efficacy

12.01.2010

Centrum® and Molly Shannon Search for 'America's Most Amazingly Energized Woman' This Holiday Season

12.01.2010

SUTENT® Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET)

11.29.2010

Caltrate® Soft Chews Offer A New and Delicious Way to Help Americans Reach Their Recommended Daily Calcium and Vitamin D Intake

11.28.2010

Pfizer to Present Data from Its Hematology Portfolio at the 52nd Annual Meeting of the American Society of Hematology

11.28.2010

Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization for the Treatment of Gaucher Disease

11.21.2010

Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.

11.18.2010

Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)

11.18.2010

APPRAISE-2 Study with Investigational Compound Apixaban in Acute Coronary Syndrome Discontinued

11.16.2010

Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco

11.15.2010

Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds

11.13.2010

Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows

11.09.2010

Lower Protein in Infant Formula Supports Growth Rate Similar to Breast Milk, New Study Shows

11.08.2010

Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's Disease

11.07.2010

In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function

11.03.2010

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

11.01.2010

Pfizer Reports Third-Quarter 2010 Results

10.28.2010

Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan

10.28.2010

Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend

10.27.2010

Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)

10.21.2010

Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.

10.20.2010

New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia

10.19.2010

Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil

10.17.2010

Biocon and Pfizer Enter Into Global Commercialization Agreement

10.13.2010

Alzheimer's Disease Caregivers Identify Memory Loss, Personal Safety and Confusion as Top Three Concerns Related to Progression of Their Loved One's Disease

10.11.2010

Pfizer to Acquire King Pharmaceuticals, Inc.

10.06.2010

Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets

10.06.2010

Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis

08.09.2010

Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A

08.02.2010

Pfizer Reports Second-Quarter 2010 Results

07.29.2010

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

07.22.2010

Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept® (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer’s Disease

07.21.2010

Pfizer To Offer Free Public Access To Mental Health Assessment Tools To Improve Diagnosis And Patient Care

07.18.2010

Pfizer Suspends Chronic Pain Studies In Tanezumab Clinical Trial Program; Some Studies Continue In Areas Of Unmet Medical Need

07.13.2010

Pfizer And SMC Collaborate On Liver Cancer

07.12.2010

New Research Presented At Alzheimer’s Association International Conference On Alzheimer's Disease Indicates Alzheimer’s Disease May Lead To Increased Comorbid Conditions And Economic Burden

07.07.2010

Pfizer To Present More Than 40 Abstracts On Pre-Clinical, Clinical And Outcomes Research At Alzheimer's Association International Conference On Alzheimer’s Disease

07.06.2010

Pfizer Strengthens Manufacturing Capabilities In Asia With Expansion Of Singapore Nutrition Plant

07.05.2010

Pfizer Announces European Union Approval Of A New Form Of Lipitor (atorvastatin) For Use In Children

06.28.2010

Pfizer Invites Public To View And Listen To Webcast Of August 3 Conference Call With Analysts

06.23.2010

Pfizer Declares An 18-Cent Third-Quarter 2010 Dividend

06.22.2010

Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program

06.20.2010

Pfizer Enters Into Agreement With Ergonex Pharma To Acquire Investigational Treatment For Pulmonary Arterial Hypertension